These trials completed more than 12 months ago and should have reported results.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
|Status||Trial ID||Title||Completion date||Category|
|Ongoing||2006-001084-27||Phase I/II study of prevention of Colorectal Cancer CRC with Allopurinol in High-Risk Subjects||not-yet-due|
|Ongoing||2007-007740-10||Randomized placebo-controlled phase III trial of low-dose tamoxifen women whit IntraEphitelial Neoplasia(IEN)||not-yet-due|
|Ongoing||2008-005206-39||Pilot Study: Iron-chelating treatment in patients with Neurodegeneration with Brain Iron Accumulation (NBIA).||not-yet-due|
|Ongoing||2009-010088-17||Whole liver iron overload measured by the biosusceptometer Magnetic Iron Detector (MID) in thalassemia and MDS patients treated with deferasirox||not-yet-due|
|Ongoing||2010-018456-27||Efficacia diagnostica della metodica 18F-DOPA-PET/TC nello studio del Neuroblastoma: confronto con scintigrafia 123I-MIBG.||not-yet-due|
|Ongoing||2012-005398-30||Diagnostic efficacy and prognostic method [18F] DOPA-PET/CT in||not-yet-due|
|Ongoing||2013-000287-29||EARLY PREDICTION OF EFFICACY OF ENDOCRINE THERAPY IN BREAST CANCER:||not-yet-due|
|Completed, but no date||2014-005140-18||Diagnostic and clinical value of fused 64CuCl2-PET/MRI in prostate cancer relapse. Comparison with multiparametric MRI (mMRI) and 18F-Choline-PET/MRI||bad-data|
|Ongoing||2015-004824-77||A randomized, phase II, double-blind, placebo-controlled, multicenter, 2x2 factorial design biomarker tertiary prevention trial of low-dose aspirin and metformin in resected stage I-III colorectal can...||not-yet-due|
|Ongoing||2018-000693-30||EXemestane in Progesterone and/or Estrogen receptor positive epithelial ovarian cancer. A Randomized phase III Trial, EXPERT.||not-yet-due|